Last month marked Women’s History Month, and in February there was International Day of Women and Girls in Science, too. But, ...

Clinical trial sponsors and contract research organisations (CROs) are expanding clinical trials internationally to access ...

Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...

The regulator has sent a complete response letter (CRL) to AbbVie for trenibotulinumtoxinE (TrenibotE), a follow-up to its ...

Regeneron has become the first company to get US approval for a gene therapy for congenital hearing loss, after the FDA gave ...

The FDA has extended its review of a new subcutaneous formulation of Sanofi's multiple myeloma therapy Sarclisa – which has long played second fiddle to Johnson & Johnson's blockbuster rival Darzalex ...

Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio, a specialist in applying AI to drug discovery that was set up last year, but until now has ...

Just days after President Trump signed an executive order to broaden access to psychedelic medicines, the United States ...

There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed ...

Berkeley, California biotech Ray Therapeutics, a specialist in the development of optogenetic therapies for eye disorders, ...

Armed with new phase 3 data, Novo Nordisk has said it will file for approval of oral formulations of its GLP-1 agonist ...

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, hit by the appreciation of the ...